Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs BGM Group Ltd. (BGM)

ADC Therapeutics SA and BGM Group Ltd. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $125.7M — 1.7× the size. ADC Therapeutics SA has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, BGM Group Ltd. leads on 8 and ADC Therapeutics SA on 6.

Valuation

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
P/E n/m 148.17 20.55
P/S 3.23 n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 (0.09) 2.87
Earnings yield (39.76%) 0.67% (15.94%)
Free cash flow yield (39.53%) 0.00% 0.00%

Profitability

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 6.54% 53.51%
Operating margin (125.08%) 0.00% 0.00%
Net margin (121.77%) 1.96% (2.45%)
Free cash flow margin (127.72%) 0.00% 0.00%
Return on equity 45.35% 0.00% (0.80%)
Return on assets (32.25%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% — 5.22%
EPS growth (last fiscal year) 30.86% 10.00% 42.91%
Revenue growth, 5-year CAGR 103.35% (5.39%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.00 0.04
Current ratio 3.03 1.25 2.41
Net debt to EBITDA 1.22 0.97 1.01

Dividend

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT BGM Drug Manufacturers Specialty & Generic median
Market cap 209.38m 125.72m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack